Southwest Oncology Group Phase II Trial (S0341) of Erlotinib (OSI-774) in Patients With Advanced Non-Small Cell Lung Cancer and a Performance Status of 2
Journal of Thoracic Oncology - United States
doi 10.1097/jto.0b013e318183aa1f
Full Text
Open PDFAbstract
Available in full text
Date
September 1, 2008
Authors
Publisher
Elsevier BV